EBIT (Annual)

EBIT: Income before interest and taxes.

Biogen Inc. (BIIB) had EBIT of $2.25B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$9.68B
Net Income	$1.63B
Cost of Goods Sold	$2.31B
Gross Profit	$7.37B
Operating Expenses	$7.43B
Operating Income	$2.25B
Non-Operating Income/Expense	$-343.60M
Pre-Tax Income	$1.91B
Normalized Pre-Tax Income	$1.91B
Income after Taxes	$1.63B
Income from Continuous Operations	$1.63B
Consolidated Net Income/Loss	$1.63B
Normalized Income after Taxes	$1.63B
EBIT	$2.25B
EBITDA	$3.21B
Weighted-Average Shares Outstanding (Basic)	145.60M
Weighted-Average Shares Outstanding (Diluted)	145.90M
Earnings per Share (EPS) (Basic)	$11.21
Earnings per Share (EPS) (Diluted)	$11.18
Balance Sheet Financials
Current Assets	$7.46B
Property, Plant, and Equipment	$3.18B
Long-Term Assets	$20.59B
Total Assets	$28.05B
Current Liabilities	$5.53B
Long-Term Debt	$4.55B
Long-Term Liabilities	$5.80B
Total Liabilities	$11.33B
Common Equity	$16.72B
Tangible Shareholders Equity	$545.90M
Shareholders Equity	$16.72B
Common Shares Outstanding	145.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.88B
Cash Flow from Investing Activities	$-799.20M
Cash Flow from Financial Activities	$-683.50M
Beginning Cash	$1.05B
End Cash	$2.38B
Increase/Decrease in Cash	$1.33B
Stock-Based Compensation	$291.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.35
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.21
Debt to Equity Ratio	0.38
Gross Margin	76.12%
Operating Margin	23.25%
EBIT Margin	23.25%
EBITDA Margin	33.21%
Pre-Tax Profit Margin	19.70%
Profit Margin	16.87%
Free Cash Flow	$2.72B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.34
Inventory Turnover	0.94
Receiveable Turnover	6.89
Days Sales in Receivables	52.99
Return on Equity	9.76%
Return on Tangible Equity	298.99%
Return on Assets	5.82%
Return on Investments	7.68%
Book Value Per Share	$114.73
Free Cash Flow per Share	$18.66
Operating Cash Flow per Share	$19.71

Data from Zacks Investment Research, Inc.